Privia Health Group Inc (PRVA)
Days of sales outstanding (DSO)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | 5.73 | 4.54 | 4.72 | 5.49 | 7.16 | 5.14 | 5.49 | 6.41 | 8.22 | ||||
| DSO | days | 63.70 | 80.47 | 77.26 | 66.51 | 50.99 | 70.98 | 66.45 | 56.95 | 44.40 |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 5.73
= 63.70
To analyze Privia Health Group Inc's Days Sales Outstanding (DSO) over the past eight quarters, we observe a fluctuating trend in collection efficiency. In Q4 2023, the DSO decreased to 64.02 days from 80.81 days in Q3 2023. This improvement may suggest faster collection of receivables or more efficient credit management practices during that period.
Comparing year-over-year performance, Q4 2023 DSO of 64.02 days is slightly higher than Q4 2022's 51.01 days. This increase implies a potential slowdown in receivables turnover efficiency or extended payment cycles in the most recent quarter compared to the same period last year.
While quarter-over-quarter variations can occur due to seasonality or business cycles, a sustained upward trend in DSO could indicate potential liquidity challenges or inefficiencies in managing accounts receivable. Conversely, a decreasing DSO trend may indicate improved cash flow and working capital management.
Further analysis and comparison with industry benchmarks or peer companies can provide additional insights into Privia Health Group Inc's effectiveness in collecting receivables and managing cash flow.
Peer comparison
Dec 31, 2023